Regeneron Pharmaceuticals Inc (NAS:REGN)
$ 714.47 -0.66 (-0.09%) Market Cap: 78.51 Bil Enterprise Value: 71.42 Bil PE Ratio: 17.68 PB Ratio: 2.68 GF Score: 88/100

Regeneron Pharmaceuticals Inc at Cowen Health Care Conference Transcript

Mar 06, 2023 / 05:50PM GMT
Release Date Price: $780.38 (+0.14%)
Tyler Martin Van Buren
Cowen and Company, LLC, Research Division - MD & Senior Equity Research Analyst

Good afternoon, everyone. I'm Tyler Van Buren here, Senior Biotech Analyst at TD Cowen. Thank you very much for joining us for TD Cowen's 43rd Annual Healthcare Conference. For our next session, very pleased to have a fireside chat with Regeneron. And it's my pleasure to introduce Marion McCourt, Executive Vice President of Commercial; and Ryan Crowe, Vice President and Head of Investor Relations. Marion and Ryan, thank you very much for being here.

Ryan Crowe
Regeneron Pharmaceuticals, Inc. - VP of IR

Thank you, Tyler, and thanks for hosting us here at the TD Cowen Conference. Before we get started, I just wanted to remind you that remarks made today may include forward-looking statements about Regeneron. And each forward-looking statement is subject to risks and uncertainties that could cause actual results and events to differ materially from those projected in such statements. A description of material risks and uncertainties can be found in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot